KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Staar Surgical (STAA) Equity Average (2016 - 2026)

Staar Surgical (STAA) has disclosed Equity Average for 16 consecutive years, with $349.0 million as the latest value for Q1 2026.

  • For the quarter ending Q1 2026, Equity Average fell 15.45% year-over-year to $349.0 million, compared with a TTM value of $349.0 million through Jan 2026, down 15.45%, and an annual FY2026 reading of $370.8 million, down 5.33% over the prior year.
  • Equity Average was $349.0 million for Q1 2026 at Staar Surgical, up from $345.2 million in the prior quarter.
  • Across five years, Equity Average topped out at $418.6 million in Q3 2024 and bottomed at $268.9 million in Q2 2022.
  • Average Equity Average over 5 years is $354.6 million, with a median of $349.6 million recorded in 2023.
  • The sharpest move saw Equity Average skyrocketed 30.75% in 2022, then decreased 17.54% in 2025.
  • Year by year, Equity Average stood at $329.6 million in 2022, then rose by 15.97% to $382.3 million in 2023, then increased by 7.97% to $412.7 million in 2024, then decreased by 16.37% to $345.2 million in 2025, then grew by 1.1% to $349.0 million in 2026.
  • Business Quant data shows Equity Average for STAA at $349.0 million in Q1 2026, $345.2 million in Q3 2025, and $343.3 million in Q2 2025.